Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction

American Journal of Medical Genetics

Volumn 84, Issue 3, 1999, Pages 306-308

  Syrrou, Maria ^a   Georgiou, Ioannis ^a   Patsalis, Philippos C ^b   Bouba, Ioanna ^a   Adonakis, George ^a   Pagoulatos, Gerassimos N ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Estrogen receptor; FRAXA premutations; Polymorphism; Premature ovarian failure

Indexed keywords

ESTROGEN RECEPTOR; TRINUCLEOTIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FERTILIZATION IN VITRO; FRAGILE X SYNDROME; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; OVARY DISEASE; OVARY INSUFFICIENCY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RANDOMIZED CONTROLLED TRIAL; RECEPTOR GENE; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT;

ADULT; ALLELES; FEMALE; FRAGILE X SYNDROME; HUMANS; MUTATION; OVARIAN DISEASES; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN;

EID: 0033612149     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990528)84:3<306::AID-AJMG29>3.0.CO;2-I     Document Type: Article

References (11)

1. Coulam CB, Adamson SC, Annaegers JF. 1986. Incidence of premature ovarian failure. Obstet Gynecol 67:604-610.
2. Cramer DH, Xu H, Harlow BL. 1995. Family history as a predictor of early menopause. Fertil Steril 64:740-745.
3. Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K, Hagerman RJ. 1991. Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic figures. Am J Med Genet 38:269-274.
4. Davis SR. 1996. Premature ovarian failure. Maturitas 23:1-8.
5. Fu YH, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJMH, Holden JA, Fenwick RG, Warren ST, Oostra BA, Nelson DL, Caskey CT. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
6. Issa J-P J, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. 1994. Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon. Nat Genet 7:536-540.
7. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
8. Ottaviano YL, Issa J-P J, Farl FF, Smith HS, Baylim SB, Davidson NE. 1994. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res 54:2552-2555.
9. Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, Van Der Hagen C, Delozier-Blanchet C, Croquette MF, Gilgenkrantz S, Jalbert P, Voelckel MA, Oberle I, Mandel JL. 1991. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325:1673-1681.
10. Sano M, Satoshi I, Tahayuki H, Yasuyoshi O, Mitsuru E, Masataka S, Hajime. 1995. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217: 378-383.
11. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JA, Stevenson RE. 1994. Obstetrical and gynecological complications in fragile X carriers : a multicenter study. Am J Med Genet 51:400-402.